Results 321 to 330 of about 4,600,401 (406)

Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease.

open access: yesWorld J Gastrointest Pharmacol Ther
Changela M   +10 more
europepmc   +1 more source

Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy

open access: bronze, 2000
James D. Douketis   +4 more
openalex   +1 more source

Serum metabolic and microbial profiling yields insights into promoting effect of tryptophan‐related metabolites for health longevity in centenarians

open access: yesiMeta, EarlyView.
Schematic representation of the design. Tryptophan metabolism is enriched in serum metabolites and gut microbiota of centenarians, potentially contributing to healthy longevity. A key tryptophan metabolite 5‐methoxyindoleacetic acid (5‐MIAA) is linked to the Christensenellaceae R‐7 group and exhibits effects of delaying cell senescence, promoting ...
Xiaorou Qiu   +16 more
wiley   +1 more source

Construction strategies for 3D printed cardiac tissue repair materials and their application potential

open access: yesInterdisciplinary Medicine, EarlyView.
This article provides an overview of the construction strategies of 3D printing materials in cardiac tissue repair, focusing on personalized design, advanced printing technologies, and multi‐material integration. It showcases the application of carbon‐based, biomass‐based, and bio‐based composites.
Mingru Kong   +10 more
wiley   +1 more source

Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation. [PDF]

open access: yesJ Intensive Care
Iba T   +6 more
europepmc   +1 more source

Development of a screening tool to flag older adults at a high risk of preventable medication‐related readmissions

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
Abstract Background Preventable medication‐related readmissions (pMRRs) are a significant contributor to older adult morbidity, mortality, and health care costs. There are currently no specific screening tools for identifying patients at a high risk of pMRRs.
Nicole Schönenberger   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy